Body mass index and the quality of life of endometrial cancer survivors-A systematic review and meta-analysis

Gynecologic Oncology

Volumn 137, Issue 1, 2015, Pages 180-187

  Smits, Anke ^a   Lopes, Alberto ^a   Bekkers, Ruud ^b   Galaal, Khadra ^a  

^a ROYAL CORNWALL HOSPITAL   (United Kingdom)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Body mass index; Endometrial cancer; Quality of life; Survivorship

Indexed keywords

ANXIETY; BECK DEPRESSION INVENTORY; BODY MASS; CANCER RISK; CANCER SURVIVOR; DEPRESSION; ENDOMETRIUM CANCER; FEMALE; FEMALE SEXUAL FUNCTION INDEX; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LIFESTYLE MODIFICATION; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEXUAL FUNCTION; SHORT FORM 36; SOCIAL INTERACTION; STATE TRAIT ANXIETY INVENTORY; SYSTEMATIC REVIEW; ENDOMETRIUM TUMOR; META ANALYSIS; PATHOPHYSIOLOGY; PSYCHOLOGY;

BODY MASS INDEX; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; OBESITY; QUALITY OF LIFE;

EID: 84929942838     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.01.540     Document Type: Review

References (47)

1. Cancer Research UK Oc. Ovarian cancer, statistics; 2011(updated 4 December 2013).
2. Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24million UK adults. Lancet 2014;384(9945):755-65 (Epub 2014/08/19).
3. Smits A, Lopes A, Das N, Bekkers R, Galaal K. The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter? Gynecol Oncol 2014;132(1): 137-41.
4. Fader AN, Frasure HE, Gil KM, Berger NA, von Gruenigen VE. Quality of life in endometrial cancer survivors: what does obesity have to do with it? Obstet Gynecol Int 2011;2011.
5. Von Gruenigen VE, Tian C, Frasure H, Waggoner S, Keys H, Barakat RR. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study. Cancer 2006;107(12):2786-91 (Epub 2006/11/11).
6. Nevadunsky NSVAA, Strickler HD, Moadel A, Kaur G, Levitt J, Girda E, Goldfinger M, Goldberg GL, Einstein MH. Obesity and age at diagnosis of endometrial cancer. Obstet Gynecol 2014 Aug;124(2 Pt 1):300-6.
7. Von Gruenigen VE, Gil KM, Frasure HE, Jenison EL, Hopkins MP. The impact of obesity and age on quality of life in gynecologic surgery. Am J Obstet Gynecol 2005; 193(4):1369-75.
8. Basen-Engquist K, Scruggs S, Jhingran A, Bodurka DC, Lu K, Ramondetta L, et al. Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol 2009;200(3):288.e1-8 (Epub 2008/12/27).
9. Goldfarb S, Mulhall J, Nelson C, Kelvin J, Dickler M, Carter J. Sexual and reproductive health in cancer survivors. Semin Oncol 2013;40(6):726-44 (Epub 2013/12/18).
10. Onujiogu N, Johnson T, Seo S, Mijal K, Rash J, Seaborne L, et al. Survivors of endometrial cancer: who is at risk for sexual dysfunction? Gynecol Oncol 2011;123(2): 356-9 (Epub 2011/08/23).
11. Yavas G, Dogan NU, Yavas C, Benzer N, Yuce D, Celik C. Prospective assessment of quality of life and psychological distress in patients with gynecologic malignancy: a 1-year prospective study. Int J Gynecol Cancer:Off Int J Gynecol Cancer Soc 2012; 22(6):1096-101 (Epub 2012/06/08).
12. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535 (Epub 2009/07/23).
13. Higgins JPT GS. Cochrane handbook for systematic review of interventions version 5.0.2. [cited 2014 October]; Available from http://www.cochrane-handbook.org; 2011.
14. Wells GA, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. [cited 2014 October]; Available from http://www.ohri.ca/programs/clinical- epidemiology/oxford.asp; 2014.
15. Holzner B, Bode RK, Hahn EA, Cella D, Kopp M, Sperner-Unterweger B, et al. Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research. Eur J Cancer 2006;42(18):3169-77 (Epub 2006/10/19).
16. Lin LL, Brown JC, Segal S, Schmitz KH. Quality of life, body mass index, and physical activity among uterine cancer patients. Int J Gynecol Cancer 2014;24(6):1027-32.
17. Oldenburg CS, Boll D, Nicolaije KAH, Vos MC, Pijnenborg JMA, Coebergh JW, et al. The relationship of body mass index with quality of life among endometrial cancer survivors: a study from the population-based profiles registry. Gynecol Oncol 2013;129(1):216-21.
18. Courneya KS, Karvinen KH, Campbell KL, Pearcey RG, Dundas G, Capstick V, et al. Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. Gynecol Oncol 2005;97(2):422-30.
19. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol Off J Am Soc Clin Oncol 1998; 16(1):139-44 (Epub 1998/01/24).
20. King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res Int J Qual Life Asp Treat Care Rehab 1996;5(6):555-67 (Epub 1996/12/01).
21. Blanchard CM, Stein K, Courneya KS. Body mass index, physical activity, and healthrelated quality of life in cancer survivors. Med Sci Sports Exerc 2010;42(4):665-71 (Epub 2009/12/03).
22. Paxton RJ, Phillips KL, Jones LA, Chang S, TaylorWC, Courneya KS, et al. Associations among physical activity, body mass index, and health-related quality of life by race/ ethnicity in a diverse sample of breast cancer survivors. Cancer 2012;118(16): 4024-31 (Epub 2012/01/19).
23. Dieperink KB, Hansen S, Wagner L, Johansen C, Andersen KK, Hansen O. Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer. Acta Oncol 2012;51(6):722-9 (Epub 2012/07/17).
24. Mosher CE, Sloane R, Morey MC, Snyder DC, Cohen HJ, Miller PE, et al. Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors. Cancer 2009;115(17):4001-9 (Epub 2009/07/29).
25. Jansen L, Koch L, Brenner H, Arndt V. Quality of life among long-term (≥5 years) colorectal cancer survivors-systematic review. Eur J Cancer 2010;46(16):2879-88 (Epub 2010/07/08).
26. Janke EA, Collins A, Kozak AT. Overview of the relationship between pain and obesity: what do we know?Where do we go next? J Rehabil Res Dev 2007;44(2):245-62 (Epub 2007/06/07).
27. Eslick GD. Gastrointestinal symptoms and obesity: a meta-analysis. Obes Rev: Off J Int Assoc Stud Obes 2012;13(5):469-79 (Epub 2011/12/23).
28. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 1998; 6(Suppl. 2):51S-209S (Epub 1998/11/14).
29. Papadia A, Ragni N, SalomEM. The impact of obesity on surgery in gynecological oncology: a review. Int J Gynecol Cancer: Off J Int J Gynecol Cancer Soc 2006;16(2): 944-52 (Epub 2006/05/10).
30. Fader ANAL, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 2009 Jul;114(1): 121-7 (Epub 2009 Apr 290).
31. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983 Feb;15(1):10-7.
32. McCarroll ML, Armbruster S, Frasure HE, Gothard MD, Gil KM, Kavanagh MB, et al. Self-efficacy, quality of life, and weight loss in overweight/obese endometrial cancer survivors (SUCCEED): a randomized controlled trial. Gynecol Oncol 2014;132(2): 397-402 (Epub 2013/12/27).
33. Nock NL, Dimitropoulos A, Rao SM, Flask CA, Schluchter M, Zanotti KM, et al. Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): a randomized trial in obese endometrial cancer survivors. Contemp Clin Trials 2014;39(2):236-45 (Epub 2014/08/21).
34. Von Gruenigen V, Frasure H, Kavanagh MB, Janata J, Waggoner S, Rose P, et al. Survivors of uterine cancer empowered by exercise and healthy diet (SUCCEED): a randomized controlled trial. Gynecol Oncol 2012;125(3):699-704 (Epub 2012/04/03).
35. Donnelly CM, Blaney JM, Lowe-Strong A, Rankin JP, Campbell A, McCrum-Gardner E, et al. A randomised controlled trial testing the feasibility and efficacy of a physical activity behavioural change intervention in managing fatigue with gynaecological cancer survivors. Gynecol Oncol 2011;122(3):618-24 (Epub 2011/06/22).
36. Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, et al. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev 2012;8:CD007566 (Epub 2012/08/17).
37. Arem H, IrwinML. Obesity and endometrial cancer survival: a systematic review. Int J Obes 2013;37(5):634-9 (Epub 2012/06/20).
38. Gunderson CC, Java J, Moore KN, Walker JL. The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study. Gynecol Oncol 2014;133(1):23-7 (Epub 2014/04/01).
39. Chang JWTF, Gaupp FB, Kavanagh JJ, Winter III WE, Gosewehr JA, HuhWK. Uterine cancer. [cited 2014 October]; Available from: http://emedicine.medscape.com/article/ 258148-overview#a0101; 2013.
40. Bradley S, Rose S, Lutgendorf S, Costanzo E, Anderson B. Quality of life and mental health in cervical and endometrial cancer survivors. Gynecol Oncol 2006;100(3): 479-86 (Epub 2005/09/28).
41. Goncalves V. Long-term quality of life in gynecological cancer survivors. Curr Opin Obstet Gynecol 2010;22(1):30-5 (Epub 2009/10/08).
42. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010;67(3):220-9 (Epub 2010/03/03).
43. Gatineau MDM. Obesity and Mental Health. Oxford: National Obesity, Observatory; 2011.
44. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol Off J Am Soc Clin Oncol 1993;11(3):570-9 (Epub 1993/03/01).
45. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a qualityof- life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85(5):365-76 (Epub 1993/03/03).
46. Greimel E, Nordin A, Lanceley A, Creutzberg CL, van de Poll-Franse LV, Radisic VB, et al. Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24). Eur J Cancer 2011;47(2):183-90 (Epub 2010/09/21).
47. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998;51(11):1055-68 (Epub 1998/11/17).